#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Basal cell naevus syndrome Congenital myopathy Acute myeloid leukaemia recurrent Deafness bilateral Henoch-Schonlein purpura Arteriosclerosis Bronchopulmonary dysplasia Hypersomnia Hypophosphatasia Pleural mesothelioma malignant Hypotransferrinaemia Toxic epidermal necrolysis Thermal burn Hereditary ataxia More trials…

    Learn about Rare Diseases

    Medulloblastoma – Basic Information X-linked lymphoproliferative syndrome – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Cholangitis sclerosing – Diagnostics Ewing’s sarcoma – Treatment Synovial sarcoma metastatic – Treatment Anaplastic thyroid cancer – Basic Information Advanced systemic mastocytosis – Treatment Splenic marginal zone lymphoma Indolent systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LYSERGIDE SODIUM HYDROXIDE Mecillinam Heparin Calcium Alrefimotide Tolebrutinib Bt-001 Ziltivekimab M-(18F)-Fluorobenzylguanidine Simeticone Pervi-Fus Tamuzimod Acetate Mps-213 ZIMISLECEL SODIUM SELENITE PENTAHYDRATE Disodium Folinate Cilastatin Revumenib ALXN2420 Fludarabine More therapies…

    Learn about Your Condition

    Exudative retinopathy Hypotonia Neurofibromatosis Neonatal anoxia Gaucher's disease type I Ewing's sarcoma recurrent Hypoaesthesia Type V hyperlipidaemia Gout Labour pain Vulvovaginal candidiasis Oxygen saturation Hepatic cancer Cardiac failure acute Rheumatoid arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Tebentafusp and Pembrolizumab for Patients with Previously Treated Advanced Melanoma

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Tebentafusp
    • Dexamethasone Phosphate
    • Dexamethasone
    Austria Belgium France Germany Italy Poland +1

  • Study on INTESTIFIX for Maintaining Remission in Children and Adults with Crohn’s Disease After Exclusive Enteral Nutrition Treatment

    Recruiting

    1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Intestifix
    Germany

  • Study on the Effectiveness of Clofazimine and Drug Combination for Treating Mycobacterium abscessus Lung Disease in Adult Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mycobacterium abscessus infection
    Investigated Drugs:
    • Amikacin
    • Azithromycin
    • Bedaquiline
    Denmark

  • Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Mifepristone
    • Methotrexate
    • Letrozole
    Denmark Finland Latvia Sweden

  • Study on Treating Adynamic Bone Disorder with Teriparatide in Patients with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Teriparatide
    Denmark

  • Study on the Effectiveness of Inavolisib with Trastuzumab and Pertuzumab for Patients with HER2-Positive, HR-Positive, PIK3CA Mutant Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Inavolisib
    • Pertuzumab
    • Trastuzumab
    Belgium Germany Italy Poland Romania Slovakia +1
Previous Page
1 … 596 597 598 599 600 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!